<![CDATA[Bridging Therapy Nonresponse, High Lymphocyte Count Are Associated With Parkinsonism After Cilta-Cel in Myeloma]...
Data from a large-scale, multicenter retrospective study by the US MM Immunotherapy Consortium provide critical insights into the predictors of these adverse events related to chimeric antigen receptor (CAR) T-cell therapy. By analyzing 761 patients …